Enjoy complimentary customisation on priority with our Enterprise License!
Below are some of the key findings from this solid tumor testing market in the US analysis report
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
The growing prevalence of cancer is the primary growth factor for the solid tumor testing market in the US. Solid tumor testing evaluates the primary tumor to determine the extent of any metastasis. This testing aids the doctors to administer effective treatment options to limit the spread of cancerous cells. The growing preference for personalized medicine is encouraging the pharmaceutical companies to develop customized medicines that analyze the patient blood or tissue sample as well.
Also, the growing adoption of NGS in cancer diagnostics is the key trend driving the growth of the solid tumor testing market in the US. NGS allows multiple genomes simultaneously while allowing researchers to focus on sequenced target regions and analyze epigenetic factors. Thus, the growing prevalence of cancer coupled with the adoption of NGS in cancer diagnostics is driving the solid tumor testing market growth in the US at a CAGR of close to 11% during the forecast period.
The solid tumor testing market in the US is concentrated. The market is in the initial stage of the growth phase, and the competition is expected to become less intense by the end of the forecast period. To help clients improve their revenue shares in the market, this research report provides an analysis of the market’s competitive landscape and offers information on the products offered by various leading companies. Additionally, this solid tumor testing market in the US analysis report suggests strategies companies can follow and recommends key areas they should focus on, to make the most of upcoming growth opportunities.
The report offers a detailed analysis of several leading companies, including:
Conventional testing was the largest technology of the solid tumor testing market in the US in 2017. The market share of this segment will continue to dominate the market throughout the next five years.
The hospitals segment accounted for the largest solid tumor testing market share in the US in 2017. This segment will remain the market leader for the next five years.
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
PART 05: MARKET SIZING
PART 06: FIVE FORCES ANALYSIS
PART 07: MARKET SEGMENTATION BY TECHNOLOGY
PART 08: CUSTOMER LANDSCAPE
PART 09: SEGMENTATION BY END-USER
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
PART 12: MARKET TRENDS
PART 13: VENDOR LANDSCAPE
PART 14: VENDOR ANALYSIS
PART 15: APPENDIX
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.